Shoupeng Fu Selected Research

farrerol

1/2020	Corrigendum to 'Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways'. [Int. Immunopharmacol. 75 (2019) 105739].
10/2019	Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
7/2018	Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway.
1/2018	Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shoupeng Fu Research Topics

Disease

16	Inflammation (Inflammations) 02/2022 - 01/2014
13	Mastitis 02/2022 - 01/2018
9	Parkinson Disease (Parkinson's Disease) 01/2021 - 09/2017
8	Neuroinflammatory Diseases 01/2021 - 03/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2022 - 10/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2020
2	Colitis 07/2018 - 04/2018
1	Retinoblastoma (Glioblastoma, Retinal) 11/2022
1	Infections 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Acute Lung Injury 11/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Lung Injury 11/2021
1	Neoplasms (Cancer) 01/2021
1	Neuroblastoma 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Herpes Zoster 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2018
1	Crohn Disease (Crohn's Disease) 04/2018
1	Sepsis (Septicemia) 01/2018
1	Diarrhea 01/2018
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Fatty Liver 11/2016
1	Ketosis 11/2016

Drug/Important Bio-Agent (IBA)

17	LipopolysaccharidesIBA 02/2022 - 09/2017
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2014
4	Pharmaceutical PreparationsIBA 02/2022 - 01/2018
4	Tight Junction ProteinsIBA 12/2021 - 01/2018
4	farrerolIBA 01/2020 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2019
3	Neuroprotective AgentsIBA 01/2021 - 09/2017
3	AntioxidantsIBA 01/2021 - 01/2020
3	Butyric Acid (Butanoic Acid)IBA 01/2020 - 01/2018
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2022 - 01/2018
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2022 - 01/2018
2	evodiamineIBA 02/2022 - 01/2021
2	FlavonoidsIBA 12/2021 - 09/2017
2	OccludinIBA 12/2021 - 01/2019
2	Claudin-3IBA 12/2021 - 01/2019
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2021 - 01/2019
2	Biological ProductsIBA 11/2021 - 01/2021
2	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2021 - 05/2020
2	myricetinIBA 01/2021 - 02/2019
2	isovitexinIBA 01/2020 - 01/2019
2	licochalcone AIBA 01/2019 - 09/2017
2	Sulfonic AcidsIBA 07/2018 - 04/2018
2	sym-trinitrobenzeneIBA 07/2018 - 04/2018
2	peiminineIBA 03/2018 - 01/2018
1	Carrier Proteins (Binding Protein)IBA 11/2022
1	Arginine (L-Arginine)FDA Link 11/2022
1	Eukaryotic Initiation Factor-4EIBA 11/2022
1	Cyclin D1IBA 11/2022
1	TOR Serine-Threonine KinasesIBA 11/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2022
1	E2F1 Transcription FactorIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	CytokinesIBA 02/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	pedunculosideIBA 12/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021
1	echinocystic acidIBA 01/2021
1	CamptothecinIBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	Menthol FDA Link 08/2020
1	dehydroandrographolideIBA 01/2020
1	InflammasomesIBA 01/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2020
1	SaltsIBA 01/2020
1	SaponinsIBA 01/2020
1	SteroidsIBA 01/2020
1	schizandrin AIBA 01/2020
1	dioscinIBA 01/2020
1	beta-NaphthoflavoneIBA 01/2020
1	Volatile Fatty AcidsIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	vanillinIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	InterleukinsIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	tubeimoside IIBA 07/2018
1	EnzymesIBA 01/2018
1	Lactulose (Duphalac)FDA LinkGeneric 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	Butyrates (Butyrate)IBA 01/2018
1	polydatinIBA 01/2018
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2018
1	galanginIBA 12/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2017
1	KisspeptinsIBA 12/2017
1	Indicators and Reagents (Reagents)IBA 11/2016

Therapy/Procedure

1	Therapeutics 01/2020
1	Ligation 01/2018
1	Punctures 01/2018